Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

436 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

NCT02606877

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Southmead Hospital Bristol, United Kingdom
  • Papworth Hospital Cambridge, United Kingdom
  • Glenfield Hospital Leicester, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Completed

Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment

NCT02802345

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Pulmonary Assoc of Stamford Stamford, Connecticut, United States
  • University of Florida College of Medicine Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 85 locations
View Trial Details
Completed

Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry

NCT00540475

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
  • University of Pennsylvania Health System Philadelphia, Pennsylvania, United States
  • Temple University Philadelphia, Pennsylvania, United States
  • Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT01872689

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University Alabama At Birmingham Birmingham, Alabama, United States
  • Mayo Clinic- Scottsdale Scottsdale, Arizona, United States
  • Southern Arizona Veterans Administration Healthcare Systems Tucson, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 112 locations
View Trial Details
Completed

Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT02598193

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • David Geffen School of Medicine at UCLA;Division of Pulmonary & Critical Care/ Department of Medic Los Angeles, California, United States
  • Stanford University School of Medicine ; Pulmonary/Critical Care Medicine Stanford, California, United States
  • Sarasota Memorial Hospital Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 38 locations
View Trial Details

Related conditions